Location History:
- Uiwang-si, KR (2015 - 2017)
- Busan, KR (2019)
- Gyeongsangnam-do, KR (2020)
- Daejeon, KR (2013 - 2021)
- Changwon-si, KR (2021)
- Suwon-si, KR (2018 - 2022)
- Seoul, KR (2017 - 2023)
- Gyeonggi-do, KR (2013 - 2024)
- Incheon, KR (2017 - 2024)
- Yongin-si, KR (2017 - 2024)
- Anyang-si, KR (2019 - 2024)
- Hwaseong-si, KR (2022 - 2024)
Company Filing History:
34 out of 27,085 
32 out of 899 
4 out of 350 
Years Active: 2013-2025
Areas of Expertise:
Title: The Innovations of Ji Hye Lee: A Pioneer in Biopharmaceutical Research
Introduction: Ji Hye Lee, based in Anyang-si, South Korea, is a prominent inventor recognized for her significant contributions to the field of biopharmaceuticals. With an impressive portfolio of 39 patents, her innovative work has paved the way for advancements in therapeutic preparations and polypeptide technology.
Latest Patents: Among Ji Hye Lee's recent inventions are notable patents that address essential advancements in medicine. One such innovation is the "Parenteral liquid preparation comprising carbamate compound." This invention focuses on a parenteral liquid formulation that includes a carbamate compound, its isomers, or pharmaceutically acceptable variations, alongside a cyclodextrin derivative. Another significant patent is related to a "Polypeptide and method of producing IMP using the same,” which describes a novel polypeptide that facilitates the export of 5′-inosine monophosphate, along with methods for its production and export enhancement.
Career Highlights: Throughout her career, Ji Hye Lee has demonstrated remarkable expertise in her field. Her tenure at notable companies such as CJ CheilJedang Corporation and Dong-a St Co., Ltd. has equipped her with valuable experience in biopharmaceutical innovation. This background, combined with her inventive spirit, has allowed her to develop a diverse range of impactful solutions.
Collaborations: Ji Hye Lee has worked alongside talented individuals, including her esteemed colleagues Min Ji Baek and Hye Won Kim. Their collaborative efforts have further enriched her research and innovation journey, contributing to the successful development of her patented technologies.
Conclusion: Ji Hye Lee stands out as an influential inventor in the biopharmaceutical sector, with her extensive patent portfolio reflecting her commitment to advancing medical science. Her work continues to inspire innovation and collaboration in the industry, ensuring her contributions leave a lasting impact on the field.